Xeris Biopharma Holdings, Inc.
XERSDrugs in Pipeline
12
Phase 3 Programs
4
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How XERS's past catalysts played out
Glucagon
Diabetes Mellitus, Type 1
G-Pen (glucagon injection)
Hypoglycemia
G-Pen
Insulin Hypoglycemia
Lilly Glucagon
Insulin Hypoglycemia
Glucagon RTU
Hyperinsulinemic Hypoglycemia
Glucagon RTU Injection With Insulin Pump Reduction
Hypoglycemia
G-Pen Mini™ (glucagon injection)
Hypoglycemia
PRAM9
Diabetes Mellitus, Type 1
G-Pen(TM) 1 mg
Hypoglycemia
Novo Nordisk GlucaGen®
Hypoglycemia
levothyroxine sodium
Hypothyroidism
G-Pump™ (glucagon infusion)
Hypoglycemia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Glucagon | Phase 3 | Diabetes Mellitus, Type 1 | - | - |
G-Pen (glucagon injection) | Phase 3 | Hypoglycemia | - | - |
G-Pen | Phase 3 | Insulin Hypoglycemia | - | - |
Lilly Glucagon | Phase 3 | Insulin Hypoglycemia | - | - |
Glucagon RTU | Phase 2 | Hyperinsulinemic Hypoglycemia | - | - |
Glucagon RTU Injection With Insulin Pump Reduction | Phase 2 | Hypoglycemia | - | - |
G-Pen Mini™ (glucagon injection) | Phase 2 | Hypoglycemia | - | - |
PRAM9 | Phase 2 | Diabetes Mellitus, Type 1 | - | - |
G-Pen(TM) 1 mg | Phase 2 | Hypoglycemia | - | - |
Novo Nordisk GlucaGen® | Phase 2 | Hypoglycemia | - | - |
levothyroxine sodium | Phase 2 | Hypothyroidism | - | - |
G-Pump™ (glucagon infusion) | Phase 2 | Hypoglycemia | - | - |
Frequently asked questions
What is in Xeris Biopharma Holdings, Inc.'s drug pipeline?→
CatalystAlert tracks 12 drug candidates in Xeris Biopharma Holdings, Inc.'s (XERS) pipeline across Phase 3, Phase 2. Its lead program is Glucagon (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Xeris Biopharma Holdings, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Xeris Biopharma Holdings, Inc. (XERS) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track XERS biotech catalysts?→
Add XERS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Xeris Biopharma Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.